TrialMolecular therapy : the journal of the American Society of Gene Therapy2021

A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II.

Torayuki Okuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.